Rate of employers covering weight-loss drugs is flat, Cigna says

Core Insights - Cigna reported that the percentage of employers covering obesity drugs has remained unchanged year-over-year, indicating a stable trend in employer-sponsored health benefits [1] - Despite the flat coverage percentage, there is an observed increase in demand for obesity treatments, suggesting a growing interest among employees for these medications [1] Company Analysis - Cigna's health insurance offerings continue to include obesity drugs, reflecting the company's commitment to addressing obesity as a health issue [1] - The stable employer coverage may indicate a cautious approach from employers regarding the rising costs associated with obesity treatments, despite the increasing demand [1] Industry Trends - The demand for obesity drugs is on the rise, highlighting a potential shift in consumer behavior towards seeking medical solutions for weight management [1] - The flat coverage percentage among employers may suggest a need for further industry discussions on the cost-effectiveness and long-term benefits of obesity treatments [1]